The treatment of acute hepatic failure has developed rapidly over the last 40 years, reducing morbidity and mortality from this syndrome. Whilst this has been partly attributed to significant improvements in the specialist medical management of these patients, advances in surgical techniques and pharmaceutical developments have led to the establishment of successful liver transplantation programmes, which have improved mortality significantly.This review will examine the clinical impact of alternative methods that have been used to provide extra‐corporeal hepatic support. Non‐biological, bio‐ logical and hybrid hepatic extra‐corporeal support will be explored, offering a comprehensive historical overview and an appraisal of present and future advances.